TABLE 5.
Mesenchymal stem cells (MSCs) transplantation information according to patients’ stroke history.
Patient | Stroke type | MSC therapy after stroke | MSC therapy outcomes |
P1 | Hemorrhagic | 7 months | Major |
P2 | Ischemic | 2 weeks | Major |
P3 | Ischemic | 4 months | Major |
P4 | Hypoxic/Ischemic encephalopathy | 5 months | Major |
P5 | Ischemic | 1 year | Major |